Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer Research|February 6, 2021
Pan-Cancer Analysis of Ligand-Receptor Cross-talk in the Tumor MicroenvironmentUmesh Ghoshdastider, Neha Rohatgi, Marjan Mojtabavi Naeini, et al.
Pharmacogenomics|December 7, 2017
Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patientsNatalia Sutiman, Sylvia Chen, Khoon Lin Ling, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2015
Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancerEng Huat Tan, Daniel Shao Weng Tan, Wen Yun Li, et al.
International Journal of Cancer|April 13, 2022
A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effectsMatthew Ng, Sylvia Chen, Whee Sze Ong, et al.
The Pharmacogenomics Journal|December 10, 2019
An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patientsSylvia Chen, Wei Zhi Tan, Natalia Sutiman, et al.
Clinical Pharmacology and Therapeutics|June 25, 2020
Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation ApproachAnna Mueller-Schoell, Lena Klopp-Schulze, Werner Schroth, et al.
Nature Medicine|September 19, 2017
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinomaDaniel S W Tan, Fui Teen Chong, Hui Sun Leong, et al.
Plos One|May 9, 2015
Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsAmit Jain, Cindy Lim, Eugene MingJin Gan, et al.
Clinical Pharmacology and Therapeutics|January 11, 2023
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma ConcentrationsChiea Chuen Khor, Stefan Winter, Natalia Sutiman, et al.
NPJ Breast Cancer|March 21, 2026
A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrenceChiea Chuen Khor, Whee Sze Ong, Elaine Hsuen Lim, et al.
Pageof 9